Moneycontrol
HomeNewsBusinessReal EstateSafety First credits for LEED projects to address COVID-19, reopening strategies
Trending Topics

Safety First credits for LEED projects to address COVID-19, reopening strategies

LEED guidance outlines sustainable best practices for cleaning, workplace re-occupancy, heating, ventilation, and air conditioning (HVAC) and plumbing.

June 24, 2020 / 14:37 IST
Story continues below Advertisement

Representative image

With much of the country entering into an initial reopening phase, the US Green Building Council has released four new ‘safety-first’ pilot credits in response to COVID-19. The credits outline sustainable best practices that align with public health and industry guidelines related to cleaning and disinfecting, workplace re-occupancy, HVAC and plumbing operations.

The credits can be used by LEED projects that are certified or are undergoing certification.

Story continues below Advertisement

The Safety First credits are part of USGBC’s economic recovery strategy released in May, which focuses on sustainable solutions and prioritizes healthy people in healthy places.

The credits were created in direct response to COVID-19 and focus on the safety of those working in a building. These credits are available to all LEED 2009, LEED v4 and LEED v4.1 projects.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show